Peter T. Nower

1.3k total citations
20 papers, 901 citations indexed

About

Peter T. Nower is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Peter T. Nower has authored 20 papers receiving a total of 901 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hepatology, 11 papers in Epidemiology and 9 papers in Infectious Diseases. Recurrent topics in Peter T. Nower's work include Hepatitis C virus research (17 papers), Hepatitis B Virus Studies (10 papers) and HIV/AIDS drug development and treatment (9 papers). Peter T. Nower is often cited by papers focused on Hepatitis C virus research (17 papers), Hepatitis B Virus Studies (10 papers) and HIV/AIDS drug development and treatment (9 papers). Peter T. Nower collaborates with scholars based in United States, Germany and Canada. Peter T. Nower's co-authors include Donald R. O’Boyle, Jin-Hua Sun, Robert A. Fridell, Lourdes Valera, Chunfu Wang, Julie A. Lemm, Min Gao, Susan B. Roberts, Nicholas A. Meanwell and Lawrence B. Snyder and has published in prestigious journals such as Hepatology, Journal of Virology and Biochemical Journal.

In The Last Decade

Peter T. Nower

20 papers receiving 881 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter T. Nower United States 14 767 598 360 131 86 20 901
Tatyana Dekhtyar United States 16 619 0.8× 495 0.8× 453 1.3× 103 0.8× 98 1.1× 32 868
Rakesh Tripathi United States 20 1.0k 1.3× 859 1.4× 579 1.6× 270 2.1× 61 0.7× 43 1.5k
Tse‐I Lin Sweden 11 480 0.6× 377 0.6× 276 0.8× 126 1.0× 63 0.7× 30 670
Sonal Rajyaguru United States 18 728 0.9× 550 0.9× 589 1.6× 272 2.1× 191 2.2× 25 1.1k
Thierry Verbinnen Belgium 15 919 1.2× 841 1.4× 381 1.1× 84 0.6× 28 0.3× 39 1.0k
Yu-Ping Luong United States 8 429 0.6× 302 0.5× 218 0.6× 103 0.8× 42 0.5× 10 538
Michelle Irvin United States 11 583 0.8× 479 0.8× 305 0.8× 54 0.4× 35 0.4× 17 665
Ronald Kalmeijer Belgium 16 1.6k 2.1× 1.5k 2.5× 430 1.2× 110 0.8× 68 0.8× 34 1.8k
Annick Scholliers United States 9 385 0.5× 320 0.5× 197 0.5× 49 0.4× 28 0.3× 11 500
John R. Fulghum United States 10 394 0.5× 340 0.6× 215 0.6× 382 2.9× 20 0.2× 15 797

Countries citing papers authored by Peter T. Nower

Since Specialization
Citations

This map shows the geographic impact of Peter T. Nower's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter T. Nower with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter T. Nower more than expected).

Fields of papers citing papers by Peter T. Nower

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter T. Nower. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter T. Nower. The network helps show where Peter T. Nower may publish in the future.

Co-authorship network of co-authors of Peter T. Nower

This figure shows the co-authorship network connecting the top 25 collaborators of Peter T. Nower. A scholar is included among the top collaborators of Peter T. Nower based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter T. Nower. Peter T. Nower is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smith, Kathryn E., Peter T. Nower, Jennifer Pizzano, et al.. (2023). Abstract PR09: KRAS-targeted PROTAC degraders are broadly efficacious against KRAS-dependent tumor models. Molecular Cancer Research. 21(5_Supplement). PR09–PR09. 2 indexed citations
2.
Wang, Chunfu, Lingling Jia, Donald R. O’Boyle, et al.. (2014). Comparison of Daclatasvir Resistance Barriers on NS5A from Hepatitis C Virus Genotypes 1 to 6: Implications for Cross-Genotype Activity. Antimicrobial Agents and Chemotherapy. 58(9). 5155–5163. 54 indexed citations
3.
Belema, Makonen, Van N. Nguyen, J. Romine, et al.. (2014). Hepatitis C Virus NS5A Replication Complex Inhibitors. Part 6: Discovery of a Novel and Highly Potent Biarylimidazole Chemotype with Inhibitory Activity Toward Genotypes 1a and 1b Replicons. Journal of Medicinal Chemistry. 57(5). 1995–2012. 20 indexed citations
4.
O’Boyle, Donald R., Jin-Hua Sun, Peter T. Nower, et al.. (2013). Characterizations of HCV NS5A replication complex inhibitors. Virology. 444(1-2). 343–354. 35 indexed citations
5.
Wang, Chunfu, Jin-Hua Sun, Donald R. O’Boyle, et al.. (2013). Persistence of Resistant Variants in Hepatitis C Virus-Infected Patients Treated with the NS5A Replication Complex Inhibitor Daclatasvir. Antimicrobial Agents and Chemotherapy. 57(5). 2054–2065. 80 indexed citations
6.
Gao, Min, Donald R. O’Boyle, Julie A. Lemm, et al.. (2013). 1424 SYNERGISTIC INTERACTIONS OF HCV NS5A REPLICATION COMPLEX INHIBITORS SENSITIZE RESISTANT VARIANTS AND ENHANCE THE EFFICACY OF DACLATASVIR (DCV, BMS-790052) IN VITRO AND IN VIVO. Journal of Hepatology. 58. S573–S574. 3 indexed citations
7.
Belema, Makonen, Van N. Nguyen, Denis R. St. Laurent, et al.. (2013). HCV NS5A replication complex inhibitors. Part 5: Discovery of potent and pan-genotypic glycinamide cap derivatives. Bioorganic & Medicinal Chemistry Letters. 23(15). 4428–4435. 11 indexed citations
8.
O’Boyle, Donald R., Peter T. Nower, Jin-Hua Sun, et al.. (2013). A 96-well based analysis of replicon elimination with the HCV NS5A replication complex inhibitor daclatasvir. Journal of Virological Methods. 193(1). 68–76. 4 indexed citations
9.
Sun, Jin-Hua, Donald R. O’Boyle, Yan Zhang, et al.. (2012). Impact of a baseline polymorphism on the emergence of resistance to the hepatitis C virus nonstructural protein 5a replication complex inhibitor, BMS-790052. Hepatology. 55(6). 1692–1699. 41 indexed citations
10.
Lopez, Omar D., Van N. Nguyen, Denis R. St. Laurent, et al.. (2012). HCV NS5A replication complex inhibitors. Part 3 : discovery of potent analogs with distinct core topologies. Bioorganic & Medicinal Chemistry Letters. 23(3). 779–784. 23 indexed citations
11.
Wang, Chunfu, Lourdes Valera, Jin-Hua Sun, et al.. (2012). Hepatitis C Virus RNA Elimination and Development of Resistance in Replicon Cells Treated with BMS-790052. Antimicrobial Agents and Chemotherapy. 56(3). 1350–1358. 40 indexed citations
12.
Lemm, Julie A., John E. Leet, Donald R. O’Boyle, et al.. (2011). Discovery of Potent Hepatitis C Virus NS5A Inhibitors with Dimeric Structures. Antimicrobial Agents and Chemotherapy. 55(8). 3795–3802. 38 indexed citations
13.
Qiu, Dike, Julie A. Lemm, Donald R. O’Boyle, et al.. (2011). The effects of NS5A inhibitors on NS5A phosphorylation, polyprotein processing and localization. Journal of General Virology. 92(11). 2502–2511. 44 indexed citations
14.
Romine, J., Denis R. St. Laurent, John E. Leet, et al.. (2011). Inhibitors of HCV NS5A: From Iminothiazolidinones to Symmetrical Stilbenes. ACS Medicinal Chemistry Letters. 2(3). 224–229. 66 indexed citations
15.
Wang, Chunfu, Lingling Jia, Dike Qiu, et al.. (2011). In Vitro Activity of BMS-790052 on Hepatitis C Virus Genotype 4 NS5A. Antimicrobial Agents and Chemotherapy. 56(3). 1588–1590. 37 indexed citations
16.
17.
Lemm, Julie A., Donald R. O’Boyle, Mengping Liu, et al.. (2009). Identification of Hepatitis C Virus NS5A Inhibitors. Journal of Virology. 84(1). 482–491. 149 indexed citations
18.
O’Boyle, Donald R., Peter T. Nower, Julie A. Lemm, et al.. (2005). Development of a Cell-Based High-Throughput Specificity Screen Using a Hepatitis C Virus-Bovine Viral Diarrhea Virus Dual Replicon Assay. Antimicrobial Agents and Chemotherapy. 49(4). 1346–1353. 53 indexed citations
19.
Yannopoulos, Constantin G., et al.. (1997). 2',3'-Cyclopropanated Nucleoside Dimers. Synlett. 1997(4). 378–380. 8 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tatyana Dekhtyar Breakdown of academic impact, for papers by Rakesh Tripathi Breakdown of academic impact, for papers by Tse‐I Lin Breakdown of academic impact, for papers by Sonal Rajyaguru Breakdown of academic impact, for papers by Thierry Verbinnen Breakdown of academic impact, for papers by Yu-Ping Luong Breakdown of academic impact, for papers by Michelle Irvin Breakdown of academic impact, for papers by Ronald Kalmeijer Breakdown of academic impact, for papers by Annick Scholliers Breakdown of academic impact, for papers by John R. Fulghum
Rankless by CCL
2026